CRESTONE - Clinical study of response to seribantumab in tumors with neuregulin-1 (NRG1) Fusions - A phase 2 study of the anti-HER3 mAb for advanced or metastatic solid tumors (NCT04383210).
Meeting Abstract
Bendell, Johanna C.; Lim, Kian-Huat; Burkard, Mark E.; Lin, Jessica J.; Chae, Young Kwang; Socinski, Mark A.; Khan, Gazala; Reckamp, Karen L.; Leland, Shawn; Plessinger, Douglas; Kunkel, Lori; Dotan, Efrat; Otterson, Gregory; Ou, Sai-Hong Ignatius; Patil, Tejas; Heymach, John V.; Kim, Edward S.